Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcadia Biosciences

4.95
+0.07131.46%
Post-market: 4.950.00000.00%18:06 EDT
Volume:7.53K
Turnover:37.39K
Market Cap:6.77M
PE:-3.35
High:5.08
Open:4.77
Low:4.77
Close:4.88
Loading ...
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 02, 2025

Major Issues Report

Form 8-K - Current report
May 02, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 30, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 04, 2025

Major Issues Report

Form 8-K - Current report
Mar 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Nov 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 23, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2024

Major Issues Report

Form 8-K - Current report